Updates are available Correction dated 2024-08-07
Click to view Correction: https://doi.org/10.1186/s12920-024-01968-7
-
Authors
Bozkurt-Yozgatli, Tugce
Pehlivan, Davut
Gibbs, Richard A.
Sezerman, Ugur
Posey, Jennifer E.
Lupski, James R.
Coban-Akdemir, Zeynep
- License Information
-
More Information
Article History
Received: 4 January 2024
Accepted: 27 March 2024
First Online: 16 April 2024
Change Date: 7 August 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12920-024-01968-7
Declarations
:
: The study was approved by an institutional review board (IRB approval number: H-29697) at Baylor College of Medicine.
: All participants in the study gave written informed consent for participation and publication of clinical information.
: J.R.L. has stock ownership in 23andMe and is a paid consultant for Genomics International. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic and genomic testing offered at Baylor Genetics (BG) ( ). J.R.L. serves on the Scientific Advisory Board of BG. D.P. provides consulting service for Ionis Pharmaceuticals. The other authors declare no competing financial interests.
